Successive clinical trials for childhood acute myeloid leukemia at St Jude Children's Research Hospital, from 1980 to 2000 (original) (raw)

References

  1. Choi SI, Simone JV . Acute nonlymphocytic leukemia in 171 children. Med Pediatr Oncol 1976; 2: 119–146.
    Article CAS Google Scholar
  2. Weinstein HJ, Mayer RJ, Rosenthal DS, Camitta BM, Coral FS, Nathan DG et al. Treatment of acute myelogenous leukemia in children and adults. N Engl J Med 1980; 303: 473–478.
    Article CAS Google Scholar
  3. Athale UH, Razzouk BI, Raimondi SC, Tong X, Behm FG, Head DR et al. Biology and outcome of childhood acute megakaryoblastic leukemia: a single institution's experience. Blood 2001; 97: 3727–3732.
    Article CAS Google Scholar
  4. Dahl GV, Kalwinsky DK, Mirro Jr J, Look AT, Pui CH, Murphy SB et al. Allogeneic bone marrow transplantation in a program of intensive sequential chemotherapy for children and young adults with acute nonlymphocytic leukemia in first remission. J Clin Oncol 1990; 8: 295–303.
    Article CAS Google Scholar
  5. Kalwinsky D, Mirro Jr J, Schell M, Behm F, Mason C, Dahl GV . Early intensification of chemotherapy for childhood acute nonlymphoblastic leukemia: improved remission induction with a five-drug regimen including etoposide. J Clin Oncol 1988; 6: 1134–1143.
    Article CAS Google Scholar
  6. Arnaout MK, Radomski KM, Srivastava DK, Tong X, Belt JR, Raimondi SC et al. Treatment of childhood acute myelogenous leukemia with an intensive regimen (AML-87) that individualizes etoposide and cytarabine dosages: s. Leukemia 2000; 14: 1736–1742.
    Article CAS Google Scholar
  7. Pui CH, Mahmoud HH, Rivera GK, Hancock ML, Sandlund JT, Behm FG et al. Early intensification of intrathecal chemotherapy virtually eliminates central nervous system relapse in children with acute lymphoblastic leukemia. Blood 1998; 92: 411–415.
    CAS PubMed Google Scholar
  8. Krance RA, Hurwitz CA, Head DR, Raimondi SC, Behm FG, Crews KR et al. Experience with 2-chlorodeoxyadenosine in previously untreated children with newly diagnosed acute myeloid leukemia and myelodysplastic diseases. J Clin Oncol 2001; 19: 2804–2811.
    Article CAS Google Scholar
  9. Brenner MK, Rill DR, Moen RC, Krance RA, Mirro Jr J, Anderson WF et al. Gene-marking to trace origin of relapse after autologous bone-marrow transplantation. Lancet 1993; 341: 85–86.
    Article CAS Google Scholar
  10. Crews KR, Gandhi V, Srivastava DK, Razzouk BI, Tong X, Behm FG et al. Interim comparison of a continuous infusion vs a short daily infusion of cytarabine given in combination with cladribine for pediatric acute myeloid leukemia. J Clin Oncol 2002; 20: 4217–4224.
    Article CAS Google Scholar
  11. Klein JP, Moeschberger ML . Survival Analysis: Techniques for Censored and Truncated Data (Statistics for Biology and Health), 2nd edn. New York: Springer, 2003.
    Google Scholar
  12. Smith MA, Ries LAG, Gurney JG, Ross JA . Leukemia. In: Ries LAG, Smith MA, Gurney JG et al (eds) Cancer Incidence and Survival among Children and Adolescents: United States SEER Program 1975–1995. Bethesda, MD: National Cancer Institute, 1999, pp 17–31.
    Google Scholar
  13. Gatta G, Luksch R, Coleman MP, Corazziari I, EUROCARE Working Group. Survival from acute non-lymphocytic leukaemia (ANLL) and chronic myeloid leukaemia (CML) in European children since 1978: a population-based study. Eur J Cancer 2001; 37: 695–702.
    Article CAS Google Scholar
  14. Stevens RF, Hann IM, Wheatley K, Gray RG . Marked improvements in outcome with chemotherapy alone in paediatric acute myeloid leukemia: results of the United Kingdom Medical Research Council's 10th AML trial. MRC Childhood Leukaemia Working Party. Br J Haematol 1998; 101: 130–140.
    Article CAS Google Scholar
  15. Perel Y, Auvrignon A, Leblanc T, Vannier JP, Michel G, Nelken B et al. Impact of addition of maintenance therapy to intensive induction and consolidation chemotherapy for childhood acute myeloblastic leukemia: results of a prospective randomized trial, LAME 89/91. Leucamie Aique Myeloide Enfant. J Clin Oncol 2002; 20: 2774–2782.
    Article Google Scholar
  16. Woods WG, Kobrinsky N, Buckley JD, Lee JW, Sanders J, Neudorf S et al. Timed-sequential induction therapy improves postremission outcome in acute myeloid leukemia: a report from the Children's Cancer Group. Blood 1996; 87: 4979–4989.
    CAS PubMed Google Scholar
  17. Lehrnbecher T, Varwig D, Kaiser J, Reinhardt D, Klingebiel T, Creutzig U . Infectious complications in pediatric acute myeloid leukemia: analysis of the prospective multi-institutional clinical trial AML-BFM 93. Leukemia 2004; 18: 72–77.
    Article CAS Google Scholar
  18. Leahey AM, Teunissen H, Friedman DL, Moshang T, Lange BJ, Meadows AT . Late effects of chemotherapy compared to bone marrow transplantation in the treatment of pediatric acute myeloid leukemia and myelodysplasia. Med Pediatr Oncol 1999; 32: 163–169.
    Article CAS Google Scholar
  19. Leung W, Hudson MM, Strickland DK, Phipps S, Srivastava DK, Ribeiro RC et al. Late effects of treatment in survivors of childhood acute myeloid leukemia. J Clin Oncol 2000; 18: 3273–3279.
    Article CAS Google Scholar
  20. Abbott BL, Rubnitz JE, Tong X, Srivastava DK, Pui CH, Ribeiro RC et al. Clinical significance of central nervous system involvement at diagnosis of pediatric acute myeloid leukemia: a single institution's experience. Leukemia 2003; 17: 2090–2096.
    Article CAS Google Scholar
  21. Kalwinsky DK, Raimondi SC, Schell MJ, Mirro Jr J, Santana VM, Behm F et al. Prognostic importance of cytogenetic subgroups in de novo pediatric acute nonlymphocytic leukemia. J Clin Oncol 1990; 8: 75–83.
    Article CAS Google Scholar
  22. Rubnitz JE, Raimondi SC, Tong X, Srivastava DK, Razzouk BI, Shurtleff SA et al. Favorable impact of the t(9;11) in childhood acute myeloid leukemia. J Clin Oncol 2002; 20: 2302–2309.
    Article CAS Google Scholar
  23. Martinez-Climent JA, Lane NJ, Rubin CM, Srivastava DK, Razzouk BI, Shurtleff SA et al. Clinical and prognostic significance of chromosomal abnormalities in childhood acute myeloid leukemia de novo. Leukemia 1995; 9: 95–101.
    CAS PubMed Google Scholar
  24. Swansbury GJ, Slater R, Bain BJ, Moorman AV, Secker-Walker LM . Hematological malignancies with t(9;11)(p21–22;q23) – a laboratory and clinical study of 125 cases. European 11q23 Workshop participants. Leukemia 1998; 12: 792–800.
    Article CAS Google Scholar
  25. Wheatley K . Current controversies: which patients with acute myeloid leukaemia should receive a bone marrow transplantation? – a statistician's view. Br J Haematol 2002; 118: 351–356.
    Article Google Scholar
  26. Burnett AK, Wheatley K, Goldstone AH, Stevens RF, Hann IM, Rees JH et al. The value of allogeneic bone marrow transplant in patients with acute myeloid leukaemia at differing risk of relapse: results of the UK MRC AML 10 trial. Br J Haematol 2002; 118: 385–400.
    Article Google Scholar
  27. Coustan-Smith E, Ribeiro RC, Rubnitz JE, Razzouk BI, Pui CH, Pounds S et al. Clinical significance of residual disease during treatment in childhood acute myeloid leukaemia. Br J Haematol 2003; 123: 243–252.
    Article Google Scholar

Download references